Anti-Inflammation Property of Syzygium cumini (L.) Skeels on Indomethacin-Induced Acute Gastric Ulceration

Table 1

Malondialdehyde (MDA), oxidized glutathione (GSSG), glutathione peroxidase (GPx), nitrite contents, gastric wall mucus, and plasma TNF- in gastric tissue of SCC acute test group.

Parameter	Group 1	Group 2	Group 3	Group 4	Group 5	Group 6	Group 7
Mucus; (µg Alcian blue/g wet stomach)	19.35 ± 0.94	15.78 ± 0.33^a,c	20.74 ± 0.75^b	21.13 ± 0.98^b	23.59 ± 0.55^a,b,c	21.31 ± 0.75^a,b	16.28 ± 0.64^a,c
MDA
Plasma; (nM/mL)	17.97 ± 2.69	23.99 ± 2.49^a,c	16.54 ± 5.53^b	16.45 ± 4.04^b,c	16.01 ± 3.19^b,c	19.06 ± 2.35^a,b	19.17 ± 2.55^a,b
Tissue; (nM/mg tissue)	1.18 ± 0.11	1.55 ± 0.03^a,c	1.07 ± 0.29^b	1.03 ± 0.12^b	0.92 ± 0.04^a,b	1.04 ± 0.14^b	1.29 ± 0.06^a,b,c
GSSG; (ng/mg Protein)	0.75 ± 0.01	1.26 ± 0.04^a,c	0.99 ± 0.04^a,b	0.87 ± 0.05^a,b,c	0.81 ± 0.01^a,b,c	0.98 ± 0.04^a,b	0.87 ± 0.01^a,b,c
GPx; (U/g Protein)	2.41 ± 0.37	0.75 ± 0.19^a,c	1.17 ± 0.13^a,b,c	1.19 ± 0.16^a,b,c	2.59 ± 0.13^b,c	0.99 ± 0.05^a,b	0.89 ± 0.04^a,b,c
Nitric oxide; (nM/mg Protein)	1.02 ± 0.31	2.39 ± 0.49^a,c	1.27 ± 0.311^b,c	1.07 ± 0.37^b,c	0.68 ± 0.23^a,b,c	1.54 ± 0.18^a,b	0.78 ± 0.11^b,c
Plasma TNF-; (pg/mL)	1.71 ± 0.04	2.09 ± 0.13^a	2.07 ± 0.09^a,c	1.92 ± 0.05^a	1.83 ± 0.03^a,b	1.89 ± 0.05^a	1.80 ± 0.06^a,b

compared with normal mice group, when compared with indomethacin treated group, and when compared with omeprazole treated group.